# Use of Recombinant Hyaluronidase Human is Effective for the Use of Local Blocks for Eyelid's Surgery

> **NCT02059694** · NA · WITHDRAWN · sponsor: **Duke University**

## Conditions studied

- Upper Eyelid Surgery

## Interventions

- **DRUG:** Hyaluronidase
- **OTHER:** 2 mL of lidocaine 2% with epinephrine 1:100,000 without rHuPH20

## Key facts

- **NCT ID:** NCT02059694
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** —
- **Primary completion:** 2015-07
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2014-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02059694

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02059694, "Use of Recombinant Hyaluronidase Human is Effective for the Use of Local Blocks for Eyelid's Surgery". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02059694. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*